D.E. Shaw & Co’s Oscar Health OSCR Stock Holding History

D.E. Shaw & Co’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.1M	Sell	108,700 -822,000	-88%	-$17.7M	﹤0.01%	2813
2026 Q1	$10.7M	Buy	930,700 +270,700	+41%	+$3.81M	0.01%	1580
2025 Q4	$9.48M	Sell	660,000 -149,300	-18%	-$2.58M	0.01%	1804
2025 Q3	$15.3M	Buy	+809,300	New	+$13.3M	0.01%	1363
2023 Q1	–	Sell	-60,000	Closed	-$148K	–	4747
2022 Q4	$148K	Hold	60,000	–	–	﹤0.01%	4319
2022 Q3	$299K	Hold	60,000	–	–	﹤0.01%	4302
2022 Q2	$255K	Hold	60,000	–	–	﹤0.01%	4433
2022 Q1	$598K	Hold	60,000	–	–	﹤0.01%	4258
2021 Q4	$471K	Buy	+60,000	New	+$753K	﹤0.01%	4439

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

D.E. Shaw & Co's OSCR Position: Q2 2026 in Review

D.E. Shaw & Co increased its Oscar Health (OSCR) stake by 131% in Q2 2026, buying an estimated $154M and bringing the position to 12,643,617 shares worth $361M. The position accounts for 0.17% of the portfolio, ranked #98.

D.E. Shaw & Co first reported a position in OSCR in Q1 2022 and has held it in 17 quarters since. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

D.E. Shaw & Co held 12,643,617 shares of Oscar Health worth $361M as of Q2 2026.
D.E. Shaw & Co bought 7,158,332 Oscar Health shares in Q2 2026, an estimated $154M.
Oscar Health made up 0.17% of D.E. Shaw & Co's portfolio in Q2 2026, its #98 holding.
D.E. Shaw & Co first reported a position in Oscar Health in Q1 2022 and has held it in 17 quarters since.
402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.